fbpx Skip to main content

Return to Work Resources

THE PATH FORWARD 2.0: BIOCOM California’s RETURN TO WORK GUIDE FOR the LIFE SCIENCE INDUSTRY

Together, we’ve collaborated to combine all of our resources and help pave the path forward for our industry members. Since our first release in May of 2020, we’ve updated our Return to Work Guide to reflect all of the new and innovative solutions for transitioning the world’s largest life science community back into the lab and workplace while mitigating the spread of COVID-19. We couldn’t have done so without our steadfast Return to Work Task Force who have been committed in their efforts to lead the way during this unprecedented time for our members.

And so, without further ado, we present to you our new & improved ‘Return To Work Guide 2.0’, inclusive of an all-new vaccination section, additional testing solutions, and what it will mean for our industry as we head into 2021.

Download Guide

RETURN TO WORK RISK ASSESSMENT CHECKLIST

Download the Biocom Return to Work Risk Assessment Checklist, templated guidance document to protect the health and safety of employees and visitors entering life science facilities in the age of COVID-19.

Download Checklist

QUICK LINKS:

About the Guide About the Task Force Biocom Resources 

About the Guide

Over the past few months, the Biocom California team has had the privilege of connecting with leaders across our industry who are leading in the fight against COVID-19. Our members make up the strongest, most collaborative and most innovative life science cluster and we couldn’t be prouder to represent them and support them during this pandemic. It is with this pride and honor that we are excited to deliver this comprehensive guide, THE PATH FORWARD 2.0: BIOCOM’S RETURN TO WORK GUIDE FOR CALIFORNIA’S LIFE SCIENCE INDUSTRY.

This all-new guide released in December 2020—completely updated from our earlier version released in May—includes a section on vaccines, an updated testing and tracing solutions section, and up-to-date CDC guidelines throughout.

The intention of this resource is to establish the foundation of ideas and recommendations upon which we can build—in collaboration with members and partners—an increasingly useful guide. We stand together with our members in working tirelessly as we all strive to make the world a healthier and safer place.

About the Task Force

The Task Force is focused on three key areas: workplace preparedness, workforce preparedness, and wide-scale testing and tracing. In addition to guidance and best practice resources, free and reduced-price PPE, and unique thought leadership in these areas, the task force will conduct and evaluate an RFP to select a group of trusted suppliers to deliver affordable company-wide testing solutions that enable you to bring employees back to office spaces, manufacturing facilities, and laboratory environments in the safest and most responsible manner.

The Return to Work Guide represents the tireless work of the Task Force and the collaboration of over 60 member companies, 20 Board Members, 15 partners, and half of our staff over the past two months.

Learn More  

Biocom Return to Work Resources

Biocom’s events team has brought leading experts from around the industry to address issues related to preparing for a safe return to the workplace. To view upcoming webinars, head to our events calendar here.

Archived Webinars:

June 30 | Return to Work Series: Testing: What You as Employers Need to Know
View our second installment of the Return to Work Webinar Series focused on Testing. Topics covered by our expert panel include what employers should know about PCR testing vs. Serology testing, symptomatic vs. asymptomatic testing, financing testing, incident management and much more.

View Webinar

June 17 | Return to Work Series: COVID-19 Testing Foundations That We All Need to Know
As you are preparing to return to a physical office space, testing is top of mind for everyone. During this webinar our experts provide a foundational overview of the different testing options available including Molecular, Antigen, and Antibody.

View Webinar


May 8 | Live Webinar Discussion: Payment Protection Program (PPP) and Economic Injury Disaster Loans (EIDL)
Please join Biocom and the Small Business Administration (SBA) for a discussion about the Payment Protection Program (PPP) and Economic Injury Disaster Loans (EIDL) programs. You’ll learn about the loan and grant programs, application process, tips, and what to expect after applying, among others.

View Webinar


May 13 | CFO Series Webinar: Discussion with Chief Economist of Nasdaq
Biocom invites you to join us on Wednesday, May 13th, as we hear from Chief Economist and Senior Vice President of Nasdaq, Inc., Phil Mackintosh.

View Webinar

(Password: BiocomCFO2020)


May 13 | Return to Workplace – Insights from Life Science CEOs Across the US
Join Biocom, MassBio and Thermo Fisher Scientific as we convene industry CEOs to share their insights on COVID-19 testing, the race for a vaccine, as well as how these leaders are preparing for the return of their workforce. In this ever changing landscape guidance’s and best practices are changing every day. Join us on May 13th as CEO’s from East and West provide you with the most updated information.

View Webinar